Hot Features
Premium
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Zeitraum:
Zeichenmodus:
| Volumen | 10.397 |
|
|||||
| News | - | ||||||
| Tageshoch | 3,71 | Niedrig Hoch |
|||||
| Tagestief | 3,2125 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| GT Biopharma Inc | GTBP | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,4066 | -10,84% | 3,345 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 3,71 | 3,2125 | 3,71 | 3,345 | 3,7516 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 123 | 10.397 | US$ 3,39 | US$ 35.240 | - | 3,2125 - 16,11 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:23:36 | 21 | US$ 3,25 | USD |
Finanzwerte GTBP
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 4,61M | 1,38M | - | 0 | -7,6M | -5,50 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News GT Biopharma
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 14.2.2024 | 20:46 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 01.2.2024 | 18:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21.12.2023 | 21:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04.12.2023 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.11.2023 | 23:25 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 06.11.2023 | 23:23 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 06.11.2023 | 23:21 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 01.11.2023 | 14:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 27.10.2023 | 23:23 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 19.9.2023 | 17:56 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 22.8.2023 | 22:55 | Edgar (US Regulatory) | Form 8-K - Current report |
| 16.8.2023 | 01:29 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
Forum GT Biopharma
Keine Diskussionen Gefunden.Neuen Thread Erstellen
GTBP Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 3,80 | 3,88 | 3,2125 | 3,69 | 4.717 | -0,455 | -11,97% |
| 1 Monat | 4,58 | 4,77 | 3,2125 | 4,03 | 6.931 | -1,24 | -26,97% |
| 3 Monate | 5,538 | 6,00 | 3,2125 | 4,80 | 19.203 | -2,19 | -39,60% |
| 6 Monate | 7,35 | 9,90 | 3,2125 | 6,88 | 86.270 | -4,01 | -54,49% |
| 1 Jahr | 10,50 | 16,11 | 3,2125 | 8,62 | 227.295 | -7,16 | -68,14% |
| 3 Jahre | 345,90 | 591,993 | 3,2125 | 140,34 | 215.904 | -342,56 | -99,03% |
| 5 Jahre | 165,00 | 591,993 | 3,2125 | 154,35 | 245.191 | -161,66 | -97,97% |
